Switzer TV

 

Welcome back for another year of stock picks, top LICs and trading tips with Switzer Investing TV. Good to have you aboard.

On this kick-off ep for the new year, we're looking at roughed-up companies on the market that might be worth a second look. Quality stocks are being sold hard, resources are back in favour, and investors are asking the same uncomfortable question, is this a buying opportunity or a value trap?

In this first show of the year, Peter Switzer sits down with Adam Dawes from Shaw and Partners, Mike Gable from Fairmont Equities, and Paul Rickard from the Switzer Report to cut through the noise.

They run the ruler over some of the market’s most talked-about names, including CSL, NextDC, Xero, WiseTech, Pro Medicus, lithium plays, uranium stocks, and gold. Fundamentals meet charts, sentiment clashes with valuation, and the panel doesn’t always agree. You’ll hear why great businesses can fall a long way without anything being “wrong”, what the charts are really saying about beaten-up tech, why resources have momentum again, and whether gold is still a defensive play with upside in 2026.

Switzer Investing TV (19/12/25): Are these smashed stocks worth your time?

On this kick-off ep for the new year, we're looking at roughed-up companies on the market that might be worth a second look. Quality stocks are being sold hard, resources are back in favour, and investors are asking the same uncomfortable question, is this a buying opportunity or a value trap?

More videos

Why almost all heart disease is genetic

Dr Ross Walker explains the two main genetic causes of heart disease that make up 90% of cases.

Series: ,
Mad about Money

Peter Switzer discusses the latest market developments and what is making him mad in the latest live episode of Mad about Money.

Series: ,
Getting real about the stock market sell off!

Peter Switzer catches up with Charlie Aitken, Paul Rickard, David Zammit and Russel Pillemer.

Series: ,
Sudden cardiac death in older people

Dr Ross Walker explains what makes sudden cardiac death in older people different.

Series: ,
Why we’re really MAD about money right now!

Peter Switzer and Paul Rickard discuss the latest market developments and what is making them really mad in the latest live episode of Mad about Money.

Series: ,
Stock market disaster? Or buying opportunity?

Following the worst day for the Australian sharemarket in over a decade, Peter Switzer speaks to Julia Lee, Michael McCarthy, Charlie Aitken, Paul Rickard and ST Wong to find out how they're responding.

Series: ,
Sudden cardiac death in young people

Dr Ross Walker explains what sudden cardiac death is and what you should do if you think you could be at risk.

Series: , ,
Mad about Money

Join Peter Switzer and Paul Rickard for this week's episode of Mad about Money. 

Series: ,
Coronavirus! Dr Doom Steve Keen & Chris Joye tell you how to play it

'Old debating enemies' Steve Keen and Chris Joye weigh in on the effects of COVID-19, plus Charlie Aitken and Paul Rickard.

Series: ,
James Garner from Kazia Therapeutics (KZA)

Peter Switzer speaks to Kazia Therepeutics (KZA) CEO James Garner about the company's work to develop a new drug for cancer.

Series: ,
Why vitamins may not be good for you

In this week's The Check Up, Dr Ross Walker explains why Vitamins may not be good for you.

Series: , ,
Dr Ron Weinberger from EMvision (EMV)

For an update on the company's progress in developing a portable brain scanner for detecting stroke, EMvision (ASX: EMV) CEO Dr Ron Weinberger joins Peter Switzer.

Series: ,

Fill in the form below to subscribe to Switzer Daily and get our latest articles, videos and podcasts sent straight to your inbox

Get the latest financial, business, and political expert commentary delivered to your inbox.

When you sign up, we will never give away or sell or barter or trade your email address.

And you can unsubscribe at any time!
Subscribe
© 2006-2021 Switzer. All Rights Reserved. Australian Financial Services Licence Number 286531. 
shopping-cartphoneenvelopedollargraduation-cap linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram